Аbstract. Relevance. Over the past decades, laser devices have been regarded as the method of choice in the treatment of a wide range of skin conditions, including acne. This is the reason for the active search for new methods of therapy, adherence to which in patients with acne would be higher. From this point of view, the increase in the efficiency of broadband pulsed light (IPL) in combination with low doses of minocycline has all the prerequisites for inclusion in the therapeutic complex in the treatment of patients with acne. Purpose of the study. To study the efficacy and safety of using a combined method of therapy with broadband pulsed light and low doses of minocycline in patients with papulopustular acne, taking into account the concentration of MMP-1, MMP-2, MMP-3, MMP-9 in blood serum and the DISS index. Material and methods. Under observation were 100 patients (76 women) and (24 men) aged 18 to 45 years with a diagnosis of papulopustular form of acne, moderate severity. All patients, depending on the initial violation of the skin microbiota, were divided into two groups: group 1–50 patients, group 2–50 patients, each group was divided into subgroups depending on the type of therapy: subgroup A — 25 patients, subgroup B — 25 patients. All patients underwent a study of the concentration of MMP-1, MMP-2, MMP-3, MMP-9 in the blood serum. Research results. The results of comparing the levels of MMP-1, 2, 3, 9 and the DISHS index before and after various methods of therapy in patients with papulopustular acne, of moderate severity in subgroups 1B and 2B showed a more significant trend towards a decrease in MMP-1, 2, 3, 9 and the DISHS index relative to subgroups 1A and 2A. Conclusions. Analyzing the results of the study, we can conclude that the use of a combined method of treatment in patients with papulopustular form of acne, of moderate severity, demonstrated greater efficiency in the dynamics of reducing the levels of MMP-1, 2, 3, 9 concentrations, as well as reducing the total index DISH compared with low-dse minocycline and a topical retinoid.